Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
暂无分享,去创建一个
Matthew A. Lardy | Yuefen Zhou | S. Webber | D. Murphy | Lian-Sheng Li | P. Dragovich | Zhongxiang Sun | Amit M. Shah | M. Tsan | Rupal A Patel | L. LeBrun | M. Sergeeva | L. Kirkovsky | A. Gobbi | D. Norris | Darian M Bartkowski | Thomas M. Bertolini | T. Nolan | Jingjing Zhao | R. Kamran | Nebojša Stanković | E. Okamoto